Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
doi: 10.1093/emph/eoz037 173 HardingJE
The long-acting GLP-1 agonists segment held the largest market share of 63% in 2025, driven by the offering of once-weekly dosing, which drastically enhances patient adherence over daily therapies
Das SR, Everett B, Birtcher KK, et al
The Advanced GLP-1 Protocol by iThriveMD combines GLP-1 and GIP receptors to help regulate appetite, control blood sugar, and support weight management and metabolic health
Supporters suggest it may help reduce pain, improve tendon repair, and support a faster return to activity
US$ 27.73
US$ 21.55
US$ 22.21
US$ 29.64
US$ 28.27
